Policy responses for Kazakhstan - HSRM

Kazakhstan


Policy responses for Kazakhstan

1.5 Testing

According to Annex 31 to the Resolution of the Chief State Sanitary Doctor No. 37 of May 22, 2020, there are two types of testing:
• COVID-19 rapid testing is performed by immunochromatography based on the principles of enzyme immunoassay (ELISA) with determination of IgG/IgM class antibodies to SARS-CoV-2 coronavirus.
• -Testing by PCR

According to Annex 10 to the Resolution of the Chief State Sanitary Doctor No. 37 of May 22, 2020, rapid testing is conducted covering the following groups:
1) Persons connected with the transport activity on the railway transport, drivers engaged in international road transport of goods, as well as transit drivers;
2) employees of the central and local public authorities involved in activities to prevent the spread of COVID-19 (Ministry of Internal Affairs, Ministry of Defence, National Guard, National Security Committee, Customs Service, akimat employees, etc.);
3) employees of enterprises providing life support in quarantine regions (employees of public utilities, trade objects selling foodstuffs, medicines, catering facilities, delivering, transport, KSC, providing disinfection services, etc.);
4) patients in need of urgent outpatient consultation in connection with a serious chronic disease according to the list of the head of a medical organization, as well as patients hospitalized for emergency indications;
5) for epidemiological indications according to the decision of the Chief State Sanitary Doctor of the respective territory.

PCR testing is required:
1.  On epidemiological indications for:
1) persons hospitalized in a COVID-19 inpatient care facility;
2) patients with ARVI and pneumonia;
3) persons from close contacts for up to 14 days (with home quarantine) from COVID-19-infected persons when the contact is established and after quarantine is completed;
4) persons from among potential contacts with the diseased at establishment of the fact of contact; 
5) medical personnel with respiratory symptoms;
6) COVID-19 patients on outpatient treatment and under medical supervision of PMSP according to clinical protocol.

2 For preventive purposes for:  
1) Citizens entering Kazakhstan through the State Border Crossing Points at road and railroad crossings from the EAEC countries and the Republic of Uzbekistan;
2) persons arriving from abroad by air and placed in a quarantine facility;
3) medical workers with increased risk of COVID-19 infection (infectious disease hospitals, pulmonary clinics (departments), inpatient isolators (for asymptomatic), quarantine facilities (for healthy), reception rooms of hospitals, filters of outpatient polyclinic organizations, ambulance crews, laboratory specialists performing PCR diagnostics, employees of sanitary and epidemiological service) once a month;
4) social workers of primary health care institutions who serve their wards at home once;
5) staff of medical and social institutions) who provide services at home to wards;
6) conscripts.

3. For epidemiological surveillance purposes for:
1) patients at planned hospitalization;
2) patients in case of emergency hospitalization;
3) pregnant women and newborns in accordance with clinical protocol;
4) patients undergoing hemodialysis;
(5) Persons entering penal institutions (persons under investigation, accused or convicted);
6) Persons newly admitted to medical and social institutions, once upon registration;
7) for epidemiological reasons in accordance with the decision of the chief state sanitary doctor of the respective territory.

By 30-Apr-2020 Kazakhstan had conducted about 250,000 tests for free in four categories: 1) those who came from abroad, 2) those who were ill and who were in contact with them, 3) those who continued to work during quarantine (doctors, military, communal services, trade, and etc.) and 4) the contingent of nursing homes.

9 laboratories at oblast level – part of the influenza surveillance programme - are conducting PCR tests with the National Reference Laboratory conducting confirmatory tests.